News & events

08 May 2012Actelion presents its strategy for value creation
04 May 2012Actelion's Annual General Meeting of Shareholders held in Basel, Switzerland
02 May 2012Actelion to host Company Update Conference Call / Audiocast
30 Apr 2012Actelion's macitentan meets primary endpoint in pivotal Phase III SERAPHIN outcome study in patients with pulmonary arterial hypertension
19 Apr 2012Actelion announces first quarter 2012 financial results
02 Apr 2012Japan's Ministry of Health, Labour and Welfare grants approval for Actelion's miglustat for the treatment of Niemann-Pick type C disease
02 Apr 2012Actelion provides update on CRTH2 program
23 Feb 2012Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. enter a collaboration agreement for XIAFLEX in Canada, Australia, Brazil and Mexico
14 Feb 2012Actelion announces Full Year 2011 financial results
09 Jan 2012Actelion to present at the 30th Annual J.P. Morgan Healthcare Conference - Getting ready for Actelion's next growth phase
13 Dec 2011Actelion provides an update on the strategic agreement with Trophos S.A.
30 Nov 2011Professor Dr. Peter Gruss, President of the Max Planck Society, nominated to Actelion's Board
21 Nov 2011Judgment in litigation between Actelion and Asahi Kasei is issued by Californian Court - Original jury verdict reduced by almost USD 170 million - Actelion set to appeal the entire verdict
24 Oct 2011Actelion provides update on judgment in Asahi Kasei litigation
20 Oct 2011Actelion announces nine months 2011 financial results
27 Sep 2011Jean-Pierre Garnier elected as Chairman of Actelion's Board of Directors
29 Aug 2011Actelion reports results of exploratory study with macitentan in IPF patients - promising long-term safety and tolerability profile - efficacy data not supportive of Phase III in IPF
02 Aug 2011Actelion announces change in its Board of Directors
02 Aug 2011Actelion's selective S1P1 receptor agonist ponesimod successful in mid-stage trial for multiple sclerosis - Ponesimod to proceed to Phase III final stage of clinical development
29 Jul 2011Actelion provides update on post-trial motions in Asahi Kasei litigation
Page:  1 2 3 4 5 6 7 8 9 10 11 12 13

Corporate events

19 July 2012

HY Results 2012

18 Oct 2012

Q3 Results 2012

14 Feb 2013FY Results 2012
Learn more
 

Related links

Actelion press releases
Tracleer® congresses
Zavesca® congresses
Medieninformationen

Top of pageSendbookmarkPrint page